Dr. Abhilasha Karkey
Dr Abhilasha Karkey, an Associate Professor of Oxford University and Director of the Oxford University Clinical Research Unit Nepal (OUCRUNP), is a medical microbiologist and has worked with OUCRUNP since 2008. She has a DPhil from the University of Oxford and an MSc in Medical Microbiology from the University of Liverpool. Dr. Karkey has over a decade of experience working with Médecins Sans Frontières (MSF) often in very difficult conflict areas. Through OUCRUNP, she utilizes her expertise and experience in helping to build a strong and critical scientific community in Nepal. Dr. Karkey’s current research focuses on antimicrobial resistance in Gram-negative pathogens (Klebsiella pneumonia and Enterobacter spp) with a specific focus on the enteric pathogens Salmonella Typhi and Paratyphi A. She leads research studies focusing on the surveillance of resistant pathogens and works in close collaboration with hospitals to devise appropriate antimicrobial stewardship (AMS) and infection prevention-control (IPC) programs.
Publications:
- Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
- Global diversity and antimicrobial resistance of typhoid fever pathogens: Insights from a meta-analysis of 13,000 Salmonella Typhi genomes
- Clinical and laboratory factors associated with neonatal sepsis mortality at a major Vietnamese children’s hospital
- ACORN (A Clinically-Oriented Antimicrobial Resistance Surveillance Network) II: protocol for case based antimicrobial resistance surveillance
- Direct inference and control of genetic population structure from RNA sequencing data
- The identification of enteric fever-specific antigens for population based serosurveillance
- Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
- Global diversity and antimicrobial resistance of typhoid fever pathogens: Insights from a meta-analysis of 13,000 Salmonella Typhi genomes
- Genomic epidemiology and antimicrobial resistance transmission of Salmonella Typhi and Paratyphi A at three urban sites in Africa and Asia
- Perspectives of pharmacy employees on an inappropriate use of antimicrobials in Kathmandu, Nepal
- Use of antimicrobials during the COVID-19 pandemic: A qualitative study among stakeholders in Nepal